BD to Announce Financial Results for its First Quarter of Fiscal 2024

Rhea-AI Summary

BD (Becton, Dickinson and Company) (NYSE: BDX) will report financial results for its first quarter of fiscal year 2024 on February 1, 2024. The news release will include summary financial information for the period ending on December 31, 2023. BD management will host an audio webcast to discuss financial results and provide an update on its operations and strategy.

FRANKLIN LAKES, N.J., Jan. 4, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its first quarter of fiscal year 2024 on Thursday, February 1, 2024. A news release will be issued at approximately 6:30 a.m. Eastern Time (ET) and will be available at www.bd.com/investors, along with related presentation materials. The news release and presentation materials will include summary financial information for the company's first quarter of fiscal year 2024, which ended on December 31, 2023.

BD management will host an audio webcast at 8 a.m. ET on February 1, 2024 to discuss its financial results and provide an update on its operations and strategy. The audio webcast can be accessed at BD's investor relations website at www.bd.com/investors and a replay will be available shortly after the call at the same website.

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson. 

Contacts:
Media:				Investors:
Troy Kirkpatrick				Adam Reiffe
VP, Public Relations				Sr. Director, Investor Relations
858.617.2361				201.847.6927
troy.kirkpatrick@bd.com				adam.reiffe@bd.com

View original content:https://www.prnewswire.com/news-releases/bd-to-announce-financial-results-for-its-first-quarter-of-fiscal-2024-302026657.html

SOURCE BD (Becton, Dickinson and Company)

FAQ

When will BD report financial results for its first quarter of fiscal year 2024?

BD will report financial results on February 1, 2024.

Where can I access the news release and presentation materials?

The news release and presentation materials will be available at www.bd.com/investors.

What period does the summary financial information cover?

The summary financial information covers the first quarter of fiscal year 2024, ending on December 31, 2023.

When will the audio webcast be hosted to discuss financial results and provide an update on operations and strategy?

The audio webcast will be hosted at 8 a.m. ET on February 1, 2024.

Where can I access the audio webcast and its replay?

The audio webcast can be accessed at BD's investor relations website at www.bd.com/investors, and a replay will be available shortly after the call at the same website.